The 49% associated company of Q&M Dental previously announced that it secured medical device licences in four Asean markets on Jan 13.

EM2AI, a 49% associated company of Mainboard-listed Q&M Dental, has entered a memorandum of understanding (MOU) with a dental solutions provider to use its dental artificial intelligence (AI) solutions across 1,000 dental clinics in the region. 

This follows EM2AI’s announcement on Jan 13, about securing medical device licences in four Asean markets — Thailand, Vietnam, Indonesia and the Philippines. 

EM2AI currently sells and distributes its AI solutions in Singapore and Malaysia. Founded in 2018 and headquartered in Singapore, EM2AI has developed healthcare software for the dental industry, which it claims can serve as a “second opinion to increase diagnosis accuracy”. 

Some of EM2AI’s AI solutions include an AI-powered patient centric cloud solution, and an AI x-ray dental condition detection and automated dental charting system. 

Q&M Dental disposed of 51% interest in EM2AI in March 2024, resulting in a decrease in equity interest from 100% to 49%. 

The group says that the parties will negotiate and agree upon the terms of separate written binding agreements, and the MOU will remain in effect for six months until the definitive agreement is signed. 

Upon the agreement materialising, EM2AI will provide its dental AI solutions to over 1,000 clinics across Singapore, Malaysia, Thailand and Vietnam. 

As at 9.41am, shares in Q&M Dental are trading 0.5 cents higher or 1.82% up at 28 cents.